From The Team

Our May newsletter features a summary comparison of molnupiravir with nirmatrelvir/ritonavir (Paxlovid), a bulletin on Paxlovid, our CVD workbook, and a short animated video highlighting patients' thoughts on changing from Humira to Amgevita.

Read the newsletter here.

31 May 2022

This FAQ list answers common questions about EPiC.

29 April 2022

Our April newsletter is all about EPiC! Following extensive engagement, we've redesigned the EPiC dashboard to make it easier to use. Read about what the cilazapril, diabetes and gout themes can offer you, and learn about the features and activities in EPiC. 

Read the newsletter here.

20 April 2022

Our March newsletter covers the introduction of the COVID-19 treatment Paxlovid in New Zealand and highlights our latest educational content. You'll find new video, article, and bulletin resources covering CVD, Paxlovid, and the switch to Amgevita. 

Read the newsletter here.


12 April 2022